Gencurix Inc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.023x

Gencurix Inc cash flow conversion efficiency. Based on the latest financial reports, Gencurix Inc (229000) has a cash flow conversion efficiency ratio of 0.023x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩295.39 Million ≈ $200.18K USD) by net assets (₩12.61 Billion ≈ $8.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Gencurix Inc market cap and net worth for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Gencurix Inc (2016–2025)

Cash flow conversion efficiency of Gencurix Inc from 2016 to 2025. This chart illustrates how Gencurix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 229000 share price today for real-time trading data and today's change.

Gencurix Inc Cash Flow Conversion Ratio Explained

Gencurix Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Gencurix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gencurix Inc ranked by their cash flow conversion efficiency. Review Gencurix Inc (229000) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Health In Tech, Inc. Class A Common Stock NASDAQ:HIT	-0.154x
Blackstone Minerals Ltd AU:BSX	-0.023x
Battalion Oil Corp NYSE MKT:BATL	-1.381x
Unifin Financiera S. A. B. de C. V MX:UNIFINA	-0.199x
TINYBUILD REGSCAT3 DL-001 F:8Z3	N/A
The Australian Wealth Advisors Group Ltd AU:WAG	0.033x
Systech Bhd KLSE:0050	0.387x
Future Battery Minerals Ltd AU:FBM	-0.035x

Annual Cash Flow Conversion Efficiency for Gencurix Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Gencurix Inc from 2016 to 2025. Also see 229000 total assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩16.37 Billion ≈ $11.09 Million	₩-6.24 Billion ≈ $-4.23 Million	-0.381x	+20.79%
2024-12-31	₩14.90 Billion ≈ $10.10 Million	₩-7.17 Billion ≈ $-4.86 Million	-0.481x	+46.80%
2023-12-31	₩12.00 Billion ≈ $8.13 Million	₩-10.86 Billion ≈ $-7.36 Million	-0.905x	+43.94%
2022-12-31	₩6.48 Billion ≈ $4.39 Million	₩-10.45 Billion ≈ $-7.08 Million	-1.614x	-497.94%
2021-12-31	₩30.99 Billion ≈ $21.00 Million	₩-8.37 Billion ≈ $-5.67 Million	-0.270x	-6.05%
2020-12-31	₩53.38 Billion ≈ $36.17 Million	₩-13.59 Billion ≈ $-9.21 Million	-0.255x	+99.24%
2019-12-31	₩155.18 Million ≈ $105.16K	₩-5.22 Billion ≈ $-3.54 Million	-33.651x	-6050.17%
2018-12-31	₩9.20 Billion ≈ $6.23 Million	₩-5.03 Billion ≈ $-3.41 Million	-0.547x	+35.20%
2017-12-31	₩6.41 Billion ≈ $4.34 Million	₩-5.41 Billion ≈ $-3.67 Million	-0.844x	-15.80%
2016-12-31	₩8.20 Billion ≈ $5.56 Million	₩-5.98 Billion ≈ $-4.05 Million	-0.729x	--

About Gencurix Inc

KQ:229000 Korea Diagnostics & Research

Market Cap

$31.07 Million

₩45.85 Billion KRW

Market Cap Rank

#23452 Global

#1610 in Korea

Share Price

₩1957.00

Change (1 day)

+0.88%

52-Week Range

₩1400.00 - ₩5870.00

All Time High

₩23845.65